MARKET

TNXP

TNXP

Tonix Pharmaceut
NASDAQ
19.53
+1.75
+9.84%
Pre Market: 19.22 -0.31 -1.59% 05:15 12/05 EST
OPEN
17.77
PREV CLOSE
17.78
HIGH
20.03
LOW
17.74
VOLUME
15
TURNOVER
0
52 WEEK HIGH
130.00
52 WEEK LOW
6.76
MARKET CAP
230.00M
P/E (TTM)
-0.9714
1D
5D
1M
3M
1Y
5Y
1D
Analysts Are Bullish on Top Healthcare Stocks: Belite Bio, Inc. ADR (BLTE), Tonix Pharma (TNXP)
TipRanks · 2d ago
Tonix Pharmaceuticals Releases Report on Monoclonal Antibody for Lyme Disease Prevention
Reuters · 3d ago
Weekly Report: what happened at TNXP last week (1124-1128)?
Weekly Report · 4d ago
Tonix: Maintaining Buy Rating With Potential Tonmya Expansion Indications
Seeking Alpha · 11/24 20:35
Tonix Pharma’s IND Clearance Boosts MDD Treatment Efforts
TipRanks · 11/24 17:06
Tonix Pharmaceuticals Receives FDA IND Clearance for Phase 2 Study of TNX-102 SL in Major Depressive Disorder
Reuters · 11/24 16:24
Tonix Pharmaceuticals gets FDA clearance to develop TNX-102 for depression
Seeking Alpha · 11/24 14:23
Tonix Wins FDA Nod To Start Phase 2 Trial Of TNX-102 SL In Major depressive Disorder
NASDAQ · 11/24 12:37
More
About TNXP
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company focused on developing and commercializing therapeutics to treat and vaccines to prevent, disease and alleviate suffering. Its development portfolio is focused on central nervous system (CNS) disorders. Its product candidates include TNX-102 SL, TNX-1300, TNX-2900, TNX-1900, TNX-1500, TNX-801, TNX-1800, TNX-4200, and TNX-1700. TNX-102 SL is for the management of fibromyalgia. Its CNS portfolio includes TNX-1300 (cocaine esterase), a biologic designed to treat cocaine intoxication that has a therapy designation. Its immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. It markets Zembrace SymTouch (sumatriptan injection) 3 mg and Tosymra (sumatriptan nasal spray) 10 mg.

Webull offers Tonix Pharmaceuticals Holding Corp stock information, including NASDAQ: TNXP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TNXP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TNXP stock methods without spending real money on the virtual paper trading platform.